Ascletis Pharma Inc Sustainability Reports
Ascletis Pharma Inc. is an innovative biotechnology company engaged in the research and development, manufacturing, and commercialization of antiviral, oncology, and fatty liver disease therapies.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 254900SKEFCO9I3GPL05
FIGI: BBG00LG50P62
9 reports from 2018 to 2025
